Novel Coronavirus 2019/2020
The Galveston National Laboratory is uniquely positioned to assist with research on the new Coronavirus that appears to have originated in Wuhan, China.
Principle Investigators at UTMB have a history of research on other human Coronaviruses, including SARS (Severe Acute Respiratory Syndrome) and MERS (Middle Eastern Respiratory Syndrome). Research conducted in the Biosafety Level 3 containment labs at the GNL has resulted in a clear understanding of the pathology of these diseases and has led to the development and testing of different vaccine candidates that have proven to protect against the diseases in animal models.
Currently, the GNL, like other research labs around the world, is working with the US Centers for Disease Control to acquire an actual isolate of the virus, possibly from one of the recently-identified U.S.-based patients. Once our scientists have a sample of the virus, they can begin testing existing therapies against it and can also work to develop a new vaccine platform, respiratory therapies and diagnostic tools.